Figure 3From: Lack of association between peroxisome proliferator-activated receptors alpha and gamma2 polymorphisms and progressive liver damage in patients with non-alcoholic fatty liver disease: a case control study Prevalence of fibrosis stage > 1 in 202 biopsied patients with non-alcoholic fatty liver disease (NAFLD), subdivided according to the presence or absence of the PPARα 162Val and PPARγ2 12Ala SNPs.Back to article page